Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Agilent Brings Great Science to Life at Analytica 2024

Published 2024-04-04, 09:50 a/m
A
-

Unveiling innovative automation capabilities and transformative workflows for analytical laboratories

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is scheduled to take place from April 9 to 12 in Munich, Germany.

Visit Agilent at Hall A2, Booth 201, to learn about recently introduced products and solutions enabling key workflows that are revolutionizing laboratories across industries including pharma and biopharma, food and environment, chemical and energy, advanced materials, and molecular biology and cell analysis. Agilent technical experts will be available to share insights into these latest innovations and intuitive workflows.

  • Advanced Dilution System (ADS 2)
    Agilent's newly launched Agilent ADS 2 is an intelligent autodilutor that seamlessly integrates with Agilent autosamplers, ICP-OES (inductively coupled plasma optical emission spectrometry), or ICP-MS (inductively coupled plasma mass spectrometry) instruments. Combined with cutting-edge software, ADS 2 provides customers with a fully integrated automation workflow solution.
  • BioTek Cytation C10 Confocal Imaging Reader
    Visit the Agilent booth for an exclusive first look at the upgraded BioTek Cytation C10 system, now equipped with water immersion and confocal spinning-disk technologies. These enhancements improve image quality, minimize deleterious effects on live-cell samples, and enhance clarity for thicker samples like tissues and 3-D spheroids.
  • 1290 Infinity II Bio Online LC Solution
    The Agilent 1290 Infinity II Bio Online LC Solution will be showcased alongside the MAST aseptic sampling system and Bioreactors from Merck KGaA, Darmstadt, Germany. This powerful combination demonstrates versatility and applicability across upstream and downstream bioprocessing applications.
  • ProteoAnalyzer
    The ProteoAnalyzer is an automated capillary electrophoresis instrument designed for assessing both reduced and non-reduced protein samples. Its streamlined workflow enhances efficiency and reliability, making protein quality control a breeze.

Agilent will also host several meet-and-greet specialist sessions in the booth.

  • Tuesday, 9 April, 4:00--5:00 pm Advanced Materials, and Energy and Chemicals Pods: Battery, Semiconductors, Alternative Energies.
  • Wednesday, 10 April, 4:00”5:00 pm Biopharma Pod: Oligo Analysis, online LC/PAT, Proteoanalyzer.
  • Thursday, 11 April, 4:00”5:00 pm Food & Environmental, and Pharma Pods: Dissolving Boundaries, Unmasking PFAS and Identifying Raw materials.

Agilent subject matter experts will also speak throughout the week at forum sessions. To learn more about Agilent's complete activities at Analytica 2024 click here. Join us as we bring Great Science to Life!

About Agilent Technologies

Agilent Technologies Inc. (NYSE: NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook (NASDAQ:META).

Media Contact
Catherine Kaye
European PR Manager
Agilent Technologies
T: 07775 410632
Catherine.kaye@agilent.com

Source: Agilent Technologies Inc.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.